|
시장보고서
상품코드
1975260
단일세포 오믹스 시장 규모, 점유율, 동향 및 성장 분석 보고서(2026-2034년)Global Single-cell Omics Market Size, Share, Trends & Growth Analysis Report 2026-2034 |
||||||
단일세포 오믹스 시장 규모는 2025년 28억 5,000만 달러에서 2026년부터 2034년까지 CAGR 16.36%로 성장하여 2034년에는 111억 5,000만 달러에 달할 것으로 예측됩니다.
정밀의료와 첨단 유전체 연구가 전 세계적으로 주목받고 있는 가운데, 세계 단일세포 오믹스 시장은 강한 성장세를 보이고 있습니다. 연구자들은 특히 종양학, 면역학, 신경학 연구에서 세포의 이질성을 이해하기 위해 단일 세포 시퀀싱 기술의 채택을 확대하고 있습니다. 생명공학 연구에 대한 투자 증가, 유전체학 프로젝트에 대한 자금 확대, 만성질환의 유병률 증가가 수요를 촉진하고 있습니다. 학계와 제약사들은 표적 치료제 개발을 위한 고해상도 세포분석을 활용하기 위해 공동 연구에 박차를 가하고 있습니다.
주요 성장 요인으로는 차세대 염기서열 분석(NGS) 기술 발전, 바이오인포매틱스 통합, 실험실 워크플로우 자동화 등을 꼽을 수 있습니다. 시퀀싱 기술의 비용 절감과 단일 세포 RNA 시퀀싱 플랫폼의 확대는 시장 침투를 더욱 촉진하고 있습니다. 제약사들은 단일세포오믹스를 활용하여 신약 파이프라인을 개선하고 임상시험 실패율을 낮추기 위해 노력하고 있습니다. 또한, 재생의료 및 줄기세포 연구 분야에서의 채용 확대로 여러 치료 분야에 걸쳐 적용 범위가 확대되고 있습니다.
향후 전망으로는 더 깊은 생물학적 지식을 제공하는 AI를 활용한 데이터 분석과 멀티오믹스 통합 플랫폼이 시장에 큰 도움이 될 것으로 예상됩니다. 신흥 경제국들은 생명과학 인프라에 많은 투자를 하고 있으며, 새로운 성장 경로를 창출하고 있습니다. 전략적 제휴, 제품 혁신, 임상 연구 활동의 확대는 계속해서 경쟁 환경을 형성할 것입니다. 맞춤형 의료가 현대 의료 시스템의 중심축으로 자리 잡으면서 세계 단일 세포 오믹스 시장은 지속적으로 확대될 것으로 예상됩니다.
목차
제1장 소개
제2장 주요 요약
제3장 시장 변수, 동향, 프레임워크
제4장 세계의 단일세포 오믹스 시장 : 제품 유형별
제5장 세계의 단일세포 오믹스 시장 : 용도별
제6장 세계의 단일세포 오믹스 시장 : 최종사용자별
제7장 세계의 단일세포 오믹스 시장 : 지역별
제8장 경쟁 구도
제9장 기업 개요
KSM 26.04.03The Single-cell Omics Market size is expected to reach USD 11.15 Billion in 2034 from USD 2.85 Billion (2025) growing at a CAGR of 16.36% during 2026-2034.
The Global Single-cell Omics Market is witnessing strong momentum as precision medicine and advanced genomic research gain global traction. Researchers are increasingly adopting single-cell sequencing technologies to understand cellular heterogeneity, particularly in oncology, immunology, and neurology studies. Rising investments in biotechnology research, expanding funding for genomics projects, and the growing prevalence of chronic diseases are fueling demand. Academic institutes and pharmaceutical companies are accelerating collaborations to leverage high-resolution cellular analysis for targeted therapeutic development.
Key growth drivers include advancements in next-generation sequencing (NGS), bioinformatics integration, and automation in laboratory workflows. The declining cost of sequencing technologies and the expansion of single-cell RNA sequencing platforms are further supporting market penetration. Pharmaceutical firms are utilizing single-cell omics to improve drug discovery pipelines and reduce clinical trial failures. Moreover, increased adoption in regenerative medicine and stem cell research is expanding application scope across multiple therapeutic areas.
Looking ahead, the market is expected to benefit from AI-powered data analytics and multi-omics integration platforms that provide deeper biological insights. Emerging economies are investing heavily in life sciences infrastructure, creating new growth avenues. Strategic partnerships, product innovations, and expanding clinical research activities will continue shaping competitive dynamics. The Global Single-cell Omics Market is poised for sustained expansion as personalized medicine becomes a central pillar of modern healthcare systems.
Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:
Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.
Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.
Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.
Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.
Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.
Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.
Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.
MARKET SEGMENTATION
By Product Type
- Single-Cell Genomics
- Single-Cell Transcriptomics
- Single-Cell Proteomics
- Single-Cell Metabolomics
By Application
- Oncology
- Cell Biology
- Neurology
- Immunology
By End-User
- Pharmaceutical & Biotechnology Companies
- Academic and Research Organizations
- Hospital and Diagnostic Laboratories
- Others
COMPANIES PROFILED
- CYTENA GmbH, 10x Genomics Inc, Becton, Dickinson and Company BD, Cellenion SASU, PerkinElmer Inc, ANGLE plc, Illumina Inc, BioRad Laboratories Inc, Mission Bio Inc, Standard BioTools Inc
- We can customise the report as per your requirements.
TABLE OF CONTENTS
Chapter 1. PREFACE
- 1.1. Market Segmentation & Scope
- 1.2. Market Definition
- 1.3. Information Procurement
- 1.3.1 Information Analysis
- 1.3.2 Market Formulation & Data Visualization
- 1.3.3 Data Validation & Publishing
- 1.4. Research Scope and Assumptions
- 1.4.1 List of Data Sources
Chapter 2. EXECUTIVE SUMMARY
- 2.1. Market Snapshot
- 2.2. Segmental Outlook
- 2.3. Competitive Outlook
Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK
- 3.1. Market Lineage Outlook
- 3.2. Penetration & Growth Prospect Mapping
- 3.3. Value Chain Analysis
- 3.4. Regulatory Framework
- 3.4.1 Standards & Compliance
- 3.4.2 Regulatory Impact Analysis
- 3.5. Market Dynamics
- 3.5.1 Market Drivers
- 3.5.2 Market Restraints
- 3.5.3 Market Opportunities
- 3.5.4 Market Challenges
- 3.6. Porter's Five Forces Analysis
- 3.7. PESTLE Analysis
Chapter 4. GLOBAL SINGLE-CELL OMICS MARKET: BY PRODUCT TYPE 2022-2034 (USD MN)
- 4.1. Market Analysis, Insights and Forecast Product Type
- 4.2. Single-Cell Genomics Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 4.3. Single-Cell Transcriptomics Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 4.4. Single-Cell Proteomics Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 4.5. Single-Cell Metabolomics Estimates and Forecasts By Regions 2022-2034 (USD MN)
Chapter 5. GLOBAL SINGLE-CELL OMICS MARKET: BY APPLICATION 2022-2034 (USD MN)
- 5.1. Market Analysis, Insights and Forecast Application
- 5.2. Oncology Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 5.3. Cell Biology Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 5.4. Neurology Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 5.5. Immunology Estimates and Forecasts By Regions 2022-2034 (USD MN)
Chapter 6. GLOBAL SINGLE-CELL OMICS MARKET: BY END-USER 2022-2034 (USD MN)
- 6.1. Market Analysis, Insights and Forecast End-user
- 6.2. Pharmaceutical & Biotechnology Companies Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 6.3. Academic and Research Organizations Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 6.4. Hospital and Diagnostic Laboratories Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 6.5. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)
Chapter 7. GLOBAL SINGLE-CELL OMICS MARKET: BY REGION 2022-2034(USD MN)
- 7.1. Regional Outlook
- 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
- 7.2.1 By Product Type
- 7.2.2 By Application
- 7.2.3 By End-user
- 7.2.4 United States
- 7.2.5 Canada
- 7.2.6 Mexico
- 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
- 7.3.1 By Product Type
- 7.3.2 By Application
- 7.3.3 By End-user
- 7.3.4 United Kingdom
- 7.3.5 France
- 7.3.6 Germany
- 7.3.7 Italy
- 7.3.8 Russia
- 7.3.9 Rest Of Europe
- 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
- 7.4.1 By Product Type
- 7.4.2 By Application
- 7.4.3 By End-user
- 7.4.4 India
- 7.4.5 Japan
- 7.4.6 South Korea
- 7.4.7 Australia
- 7.4.8 South East Asia
- 7.4.9 Rest Of Asia Pacific
- 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
- 7.5.1 By Product Type
- 7.5.2 By Application
- 7.5.3 By End-user
- 7.5.4 Brazil
- 7.5.5 Argentina
- 7.5.6 Peru
- 7.5.7 Chile
- 7.5.8 South East Asia
- 7.5.9 Rest of Latin America
- 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
- 7.6.1 By Product Type
- 7.6.2 By Application
- 7.6.3 By End-user
- 7.6.4 Saudi Arabia
- 7.6.5 UAE
- 7.6.6 Israel
- 7.6.7 South Africa
- 7.6.8 Rest of the Middle East And Africa
Chapter 8. COMPETITIVE LANDSCAPE
- 8.1. Recent Developments
- 8.2. Company Categorization
- 8.3. Supply Chain & Channel Partners (based on availability)
- 8.4. Market Share & Positioning Analysis (based on availability)
- 8.5. Vendor Landscape (based on availability)
- 8.6. Strategy Mapping
Chapter 9. COMPANY PROFILES OF GLOBAL SINGLE-CELL OMICS INDUSTRY
- 9.1. Top Companies Market Share Analysis
- 9.2. Company Profiles
- 9.2.1 CYTENA GmbH
- 9.2.2 10x Genomics Inc
- 9.2.3 Becton
- 9.2.4 Dickinson And Company (BD)
- 9.2.5 Cellenion SASU
- 9.2.6 PerkinElmer Inc
- 9.2.7 ANGLE Plc
- 9.2.8 Illumina Inc
- 9.2.9 Bio-Rad Laboratories Inc
- 9.2.10 Mission Bio Inc
- 9.2.11 Standard BioTools Inc
